Biological and genetic heterogeneity of human immunodeficiency virus type 1 (HIV-1), an etiologic agent of AIDS, has been studied extensively (for reviews, see references 9 and 14) . HIV-1 strains show various cell tropisms, cytopathic effects, neutralizations by antibodies, nucleotide sequences, etc. (4, 7, 22, 37) . This variability of HIV-1 and HIV-1 variants may be significant in their induction of various diseases. The cooperative effects of HIV-1 strains of various genetic forms, including replication-defective forms, may be required for pathogenesis (9, 36) . Some variants with tropic effects for specific cell types may cause specific diseases. Thus, the virology and molecular biology of HIV-1 variants could be of importance in the pathology of HIV-1.
HIV-1 isolates show differences in cell tropism. Among cells bearing the CD4 antigen, which is a major cellular receptor for HIV-1, some tumor T-cell lines and fresh macrophages are permissive to certain groups of HIV-1 isolates, but not to others (4, 24, 34) . The abilities of various HIV-1 isolates to infect CD4-negative glial cells and fibroblastoid cells have been shown to differ (3, 33) . Recently, we cultivated fibroblastlike cell strains derived from human brain, named BT cell strains, and isolated an HIV-1 variant 
MATERIALS AND METHODS
Cell culture and virus isolates. Human T-cell lines and and the U937 monocyte cell line (29) were maintained in RPMI 1640 medium with 10% (vol/vol) heat-inactivated fetal calf serum. Fibroblastlike cell strains BT-2 and BT-3, derived from surgically dissected human brain tumors, astrocytoma and meningioma, respectively (9a), were usually cultured in RPMI 1640 medium containing 10% fetal calf serum, 90 jig of heparin per ml, 10 jig of endothelial cell growth supplement per ml, and 10 ng of epidermal growth factor per ml. These cells showed fibroblastlike morphology and stopped growing after 10 to 15 cell passages. These cells were considered to be derived from normal blood vessel cells, because they were negative for glial fibrillary acidic protein, factor VIII-related antigens, or macrophage markers but monoclonal antibodies against BT-3 cells reacted with blood vessels of glioma tissue. Medium free of heparin, endothelial cell growth supplement, and epidermal growth factor was used during infection of BT cells with HIV-1. Cloning and Southern blot hybridization. High-molecularweight DNAs were extracted from HIV-1-infected cells as described previously (16) . Genomic libraries were constructed by ligating EMBL3 DNA (Stratagene) digested with BamHI-EcoRI and high-molecular-weight DNAs partially digested with BamHI. In vitro packaging of DNA was performed with Gigapack Gold (Stratagene). Clones containing HIV-1 genomes were selected from about 2 x 107 plaques by plaque hybridization with the use of 32P-labeled BH10 probe (Biotech Research Laboratories) (27) . Southern blot analysis of DNAs of phage clones was carried out by the standard procedure (16) , except that DNAs were blotted onto Zeta probe membranes (Bio-Rad Laboratories) by the alkaline blotting method (21) . The blots were hybridized with nick-translated DNA of the whole or a part of the BH10 probe.
Construction of recombinant viruses and transfection. DNAs of phage clones were digested with BamHI, BamHIPstI, and PstI and ligated to the corresponding restriction sites of pUC119 (35) . Colonies harboring plasmids containing parts of the HIV-1 genome were selected by colony hybridization with 32P-labeled BH10 probe. The inserts of subclones were isolated by digestion with restriction enzymes and then electrophoresis in agarose gel. Samples of about 1 pmol of each fragment were mixed in various combinations and ligated in 20 pd of solution, using DNA ligation kits (Takara Shuzo) and following the instructions of the supplier. Ligated DNAs were precipitated with ethanol and transfected into MT-4 or U937 cells by a modified DEAE-dextran method (2) . Samples of 2 x 106 MT-4 or U937 cells were collected and washed with 5 ml of Trisbuffered saline (25 mM Tris hydrochloride, 137 mM NaCl, 5 mM KCl, 0.7 mM CaCl2, 0.5 mM MgCl2, 0.6 mM Na2HPO4 [pH 7.4]) by centrifugation. Then the cells were resuspended with 0.56 ml of Tris-buffered saline and mixed with ligated DNA redissolved with 10 RI of Tris-EDTA buffer (10 mM Tris hydrochloride, 1 mM EDTA [pH 7.5]) and 30 ,lI of 10 mg of DEAE-dextran per ml. After incubation for 15 min at room temperature, the cells were collected by centrifugation and seeded into 35-mm dishes in 1.5 ml of RPMI 1640 medium containing 10% fetal calf serum. Virus replication in transfectants was monitored every 3 or 4 days by indirect immunofluorescence assay as described before (32) . Culture supernatants of the transfectants, 90% of which were HIV-1 antigen positive, were passed through 0.22-,um membrane filters (Millipore Corp.), and aliquots were stored at -70°C until use. Recombinant viruses as well as their parental viruses were capable of infecting MT-4, MOLT-4, and U937 cells and phytohemagglutinin-stimulated peripheral blood lymphocytes, although they showed variable kinetics of infections (9a) . Quantitative comparison of susceptibilities of various CD4-positive cells to the recombinant viruses is under investigation.
Virus assay. Particle-associated reverse transcriptase activity was measured as described previously (10) . Detection of cells expressing HIV-1 antigens by indirect immunofluorescence was carried out as described before (32 4 ) were synthesized in a 7500 DNA synthesizer (MilliGen) and used for determination of nucleotides 831, 1438, and 2285 of GV32, GV33, GV3452, GW31, GW33, and mutated . The BglII-DraI fragments containing residue 831 and the BglII-HaeIII fragments containing residue 1438 were excised from DNAs amplified with the primer pairs 0-N plus 0-C and 1-N plus 1-C, respectively, and inserted into BamHI-HincII-digested pUC118. The PstI-AluI fragments containing residue 2285 were excised from DNAs amplified by using the 2-N-plus-2-C pair and cloned after insertion into the PstI and SmaI sites of pUC118.
Site-directed mutagenesis. Oligonucleotide-directed mutagenesis was performed by a modification of the protocol described previously (12), using site-directed mutagenesis system Mutan-K (Takara Shuzo) according to the manufacturer's manual. Oligonucleotides 5'-CTATAGGATCAGG GAGA-3' and 5'-CTATAGGACCAGGGAGA-3' were used for mutating nucleotide 831 of the Ps-b fragment from C to T and from T to C, respectively. The mutant Ps-b fragments were partially sequenced for examination of residues 831, 1438, and 2285, and then these fragments were used for construction of recombinant viruses.
Nucleotide sequence accession numbers. The GenBank accession numbers for sequences of the Ps-b fragments of GV31 and GW32 are M59192 and M59193, respectively. Infection of BT-3 cells with recombinant viruses. DNA fragments containing parts of the HIV-1 genomes, which were obtained by digestion of the DNAs of GV31, GV51, GW32, and GW51 with BamHI, BamHI-PstI, or PstI, were subcloned and isolated. Genomes of various recombinant viruses (rl through rlO in Fig. 3 ) were reconstituted by mixing and ligating the DNA fragments in various combinations. Recombinant genomes were transfected into a human T-lymphotropic virus type 1-transformed T-cell line, MT-4, by the DEAE-dextran method, and the viruses were obtained. In all cases, expression of HIV-1 antigens in transfected MT-4 cells was detected about 10 days after transfection. Over 90% of the cells became positive for HIV-1 antigens, and cytopathic effects were observed in MT-4 cells 2 to 3 weeks after transfection. Recombinant viruses were obtained as filtered supernatants, quantitated by reverse transcriptase assay, and inoculated onto BT-3 and MT-4 cells at a virus concentration of 200,000 cpm of reverse transcriptase activity per ml. Reverse transcriptase activity in culture supernatant, syncytium induction in BT-3 cells, and expression of HIV-1 antigen were examined ( Fig. 2 and  3 Sequence analyses of the Ps-b fragments of GV31 and GW32. To specify the genetic determinant of infectivity of BT cells further, we compared the nucleotide sequences of the Ps-b fragments of GV31 and GW32 (Fig. 4) . The nucleotide sequences of 2,291-bp-long Ps-b fragments of GV31 and GW32 both contained open reading frames corresponding to parts of env, rev, and tat coding sequences, and these sequences were identical except for three nucleotide exchanges: the cytosine (C) residues in GW32 at nucleotides 831, 1438, and 2285 from the upper PstI site were replaced by thymine (T) in GV31 (Fig. 4) . There was no difference in nucleotide sequence corresponding to the putative CD4-binding region of the env protein (13) between GV31 and GW32. C to T substitutions at positions 831 and 1438 were expected to change the 311th amino acid of the env protein from proline to serine and its 513th amino acid from alanine to valine, respectively, as the first nucleotide of the Ps-b fragment was shown to be nucleotide 101 of the env coding sequence by sequence analysis of the region upstream of the Ps-b fragment (data not shown). The substitution at position 2285 was expected not to change any amino acid in the env protein, but to change an amino acid in the rev protein from proline to serine. One or more of these changes were considered to be responsible for the host range difference. HIV[GUN-1TCCI was as infectious to BT-3 (Table 3) (25) , and RF (28) . All (6) . Subtle changes in the amino acid sequence of gpl20 similar to those reported by others (6) and by us might explain some of other host range differences among HIV-1 strains.
Amino acid 311 is located in a variable region of gpl20.
The sequences of about 30 amino acids around amino acid 311 of gpl20 show up to 70% heterogeneity in various HIV-1 strains (Fig. 5) . This domain contains type-specific epitopes for neutralization (8, 11, 15, 17) and cytotoxic T lymphocytes (30, 31) . The sequence of four amino acids corresponding to residues 309 to 312 of HIV[GUN-1] gpl20 is conserved in many HIV-1 isolates including HIV[GUN-lwT] as glycineproline-glycine-arginine (Fig. 5) . This sequence has been suggested to have a 1-turn configuration and to be significant in virus infection and neutralization (8, 17, 38 There are several reports showing that HIV-1 was infectious to glial and fibroblastlike cells (3, 5, 33 
